A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

Adenocarcinoma Of The Pancreas

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

10.1023/b:drug.0000036689.28596.c6 ◽

2004 ◽

Vol 22 (4) ◽

pp. 467-473 ◽

Cited By ~ 1

Author(s):

Robert P. Whitehead ◽

Jacqueline K. Benedetti ◽

James L. Abbruzzese ◽

Bach Ardalan ◽

Stephen Williamson ◽

...

Keyword(s):

Colorectal Cancer ◽

Pilot Study ◽

Continuous Infusion ◽

Phase Ii ◽

Low Dose ◽

High Dose ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

American Journal of Hematology ◽

10.1002/ajh.20994 ◽

2007 ◽

Vol 82 (12) ◽

pp. 1056-1062 ◽

Cited By ~ 17

Author(s):

Stephen H. Petersdorf ◽

Cathryn Rankin ◽

David R. Head ◽

Howard R. Terebelo ◽

Cheryl L. Willman ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

High Dose ◽

Oncology Group ◽

Oncology Group Study ◽

High Dose Cytarabine ◽

Acute Myeloid

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)99026-e ◽

1995 ◽

Vol 12 (3) ◽

pp. 324

Keyword(s):

Low Dose ◽

Locally Advanced ◽

Small Cell ◽

High Dose ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Thoracic Irradiation ◽

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

10.1023/b:drug.0000026261.76197.54 ◽

2004 ◽

Vol 22 (3) ◽

pp. 335-341 ◽

Cited By ~ 2

Author(s):

Robert P. Whitehead ◽

Jacqueline K. Benedetti ◽

James L. Abbruzzese ◽

Bach Ardalan ◽

J. Wendall Goodwin ◽

...

Keyword(s):

Continuous Infusion ◽

Pancreatic Adenocarcinoma ◽

Low Dose ◽

Phase Ii Study ◽

High Dose ◽

Oncology Group ◽

Oncology Group Study ◽

Advanced Pancreatic Adenocarcinoma

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study

Journal of Neuro-Oncology ◽

10.1007/bf01050266 ◽

1993 ◽

Vol 15 (1) ◽

pp. 75-77 ◽

Cited By ~ 116

Author(s):

J. Wendall Goodwin ◽

John Crowley ◽

Harmon J. Eyre ◽

Benjamin Stafford ◽

Kurt A. Jaeckle ◽

...

Keyword(s):

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19951201)76:11<2248::aid-cncr2820761111>3.0.co;2-y ◽

1995 ◽

Vol 76 (11) ◽

pp. 2248-2252 ◽

Cited By ~ 51

Author(s):

Stanley P. Balcerzak ◽

Jacqueline Benedetti ◽

Geoffrey R. Weiss ◽

Ronald B. Natale

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Trial ◽

Soft Tissue Sarcomas ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study

10.1007/s10637-006-9244-8 ◽

2006 ◽

Vol 24 (6) ◽

pp. 537-542 ◽

Cited By ~ 7

Author(s):

James H. Doroshow ◽

Sheryl McCoy ◽

John S. Macdonald ◽

Brian F. Issell ◽

Taral Patel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Adenocarcinoma ◽

Oncology Group ◽

Oncology Group Study ◽

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

10.1007/bf00216928 ◽

1990 ◽

Vol 8 (1) ◽

pp. 77-80 ◽

Cited By ~ 5

Author(s):

Sarah A. Taylor ◽

Thomas Fleming ◽

Daniel D. Von Hoff ◽

Joseph D. McCracken ◽

Ronald M. Bukowski ◽

...

Keyword(s):

Pancreatic Carcinoma ◽

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Advanced Pancreatic Carcinoma

Short-term chemotherapy of poor-prognosis metastatic breast cancer with three non-cross resistant chemotherapy regimens. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19870115)59:2<239::aid-cncr2820590211>3.0.co;2-c ◽

1987 ◽

Vol 59 (2) ◽

pp. 239-244 ◽

Cited By ~ 11

Author(s):

Frederick R. Ahmann ◽

Reginald Pugh

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Poor Prognosis ◽

Metastatic Breast ◽

Oncology Group ◽

Short Term ◽

Oncology Group Study ◽

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study☆☆☆

Gynecologic Oncology ◽

10.1016/0090-8258(92)90261-g ◽

1992 ◽

Vol 46 (2) ◽

pp. 230-232 ◽

Cited By ~ 4

Author(s):

Holly H. Gallion ◽

P.Y. Liu ◽

David E. Alberts ◽

Robert V. O'Toole ◽

Janet O'Sullivan ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Previously Treated Patients ◽

Previously Treated